Literature DB >> 14761684

Neuronal nitric oxide synthase and N-methyl-D-aspartate neurons in experimental carbon monoxide poisoning.

Stephen R Thom1, Donald Fisher, Jie Zhang, Veena M Bhopale, Bruce Cameron, Donald G Buerk.   

Abstract

We measured changes in nitric oxide (NO) concentration in the cerebral cortex during experimental carbon monoxide (CO) poisoning and assessed the role for N-methyl-d-aspartate receptors (NMDARs), a glutamate receptor subtype, with progression of CO-mediated oxidative stress. Using microelectrodes, NO concentration was found to nearly double to 280 nM due to CO exposure, and elevations in cerebral blood flow, monitored as laser Doppler flow (LDF), were found to loosely correlate with NO concentration. Neuronal nitric oxide synthase (nNOS) activity was the cause of the NO elevation based on the effects of specific NOS inhibitors and observations in nNOS knockout mice. Activation of nNOS was inhibited by the NMDARs inhibitor, MK 801, and by the calcium channel blocker, nimodipine, thus demonstrating a link to excitatory amino acids. Cortical cyclic GMP concentration was increased due to CO poisoning and shown to be related to NO, versus CO, mediated guanylate cyclase activation. Elevations of NO were inhibited when rats were infused with superoxide dismutase and in rats depleted of platelets or neutrophils. When injected with MK 801 or 7-nitroindazole, a selective nNOS inhibitor, rats did not exhibit CO-mediated nitrotyrosine formation, myeloperoxidase (MPO) elevation (indicative of neutrophil sequestration), or impaired learning. Similarly, whereas CO-poisoned wild-type mice exhibited elevations in nitrotyrosine and myeloperoxidase, these changes did not occur in nNOS knockout mice. We conclude that CO exposure initiates perivascular processes including oxidative stress that triggers activation of NMDA neuronal nNOS, and these events are necessary for the progression of CO-mediated neuropathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761684     DOI: 10.1016/j.taap.2003.09.017

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

1.  Intravascular neutrophil activation due to carbon monoxide poisoning.

Authors:  Stephen R Thom; Veena M Bhopale; Shih-Tsung Han; James M Clark; Kevin R Hardy
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

Review 2.  Anesthesia-Related Carbon Monoxide Exposure: Toxicity and Potential Therapy.

Authors:  Richard J Levy
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

3.  Xanthine oxidoreductase and neurological sequelae of carbon monoxide poisoning.

Authors:  Shih-Tsung Han; Veena M Bhopale; Stephen R Thom
Journal:  Toxicol Lett       Date:  2007-02-20       Impact factor: 4.372

4.  Delayed neuropathology after carbon monoxide poisoning is immune-mediated.

Authors:  Stephen R Thom; Veena M Bhopale; Donald Fisher; Jie Zhang; Phyllis Gimotty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

5.  Impaired mitochondrial respiration and protein nitration in the rat hippocampus after acute inhalation of combustion smoke.

Authors:  Heung M Lee; Jason Reed; George H Greeley; Ella W Englander
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-24       Impact factor: 4.219

6.  Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition.

Authors:  Tomosuke Nakano; Toshiki Hasegawa; Dai Suzuki; Eishi Motomura; Motohiro Okada
Journal:  Biomolecules       Date:  2019-05-17

7.  Perinatal Carbon Monoxide Poisoning: Treatment of a 2-Hour-Old Neonate with Hyperbaric Oxygen.

Authors:  Allyson A Kreshak; Shelley M Lawrence; Sam T Ontiveros; Tiffany Castellano; Karen B VanHoesen
Journal:  AJP Rep       Date:  2022-03-09

Review 8.  Neurocognitive sequelae after carbon monoxide poisoning and hyperbaric oxygen therapy.

Authors:  Ke Ning; Yan-Yan Zhou; Ning Zhang; Xue-Jun Sun; Wen-Wu Liu; Cui-Hong Han
Journal:  Med Gas Res       Date:  2020 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.